|
1
|
Fitzpatrick JM: Facts and future lines of
research in lower urinary tract symptoms in men and women: An
overview of the role of α1-adrenoreceptor antagonist. BJU Int.
85:(Suppl 2). 1–5. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Møller LA, Lose G and Jørgensen T: The
prevalence and bothersomeness of lower urinary tract symptoms in
women 40–60 years of age. Acta Obstet Gynecol Scand. 79:298–305.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wennberg AL, Molander U, Fall M, Edlund C,
Peeker R and Milsom I: A longitudinal population-based survey of
urinary incontinence, overactive bladder and other lower urinary
tract symptoms in women. Eur Urol. 55:783–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wehrberger C, Madersbacher S, Jungwirth S,
Fischer P and Tragl KH: Lower urinary tract symptoms and urinary
incontinence in a geriatric cohort - a population-based analysis.
BJU Int. 110:1516–1521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coyne KS, Sexton CC, Thompson CL, Milsom
I, Irwin D, Kopp ZS, Chapple CR, Kaplan S, Tubaro A, Aiyer LP and
Wein AJ: The prevalence of lower urinary tract symptoms (LUTS) in
the USA, the UK and Sweden: Results from the Epidemiology of LUTS
(EpiLUTS) study. BJU Int. 104:352–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coyne KS, Sexton CC, Bell JA, Thompson CL,
Dmochowski R, Bavendam T, Chen CI and Quentin Clemens J: The
prevalence of lower urinary tract symptoms (LUTS) and overactive
bladder (OAB) by racial/ethnic group and age: Results from
OAB-POLL. Neurourol Urodyn. 32:230–237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi YS, Kim JC, Lee KS, Seo JT, Kim HJ,
Yoo TK, Lee JB, Choo MS, Lee JG and Lee JY: Analysis of female
voiding dysfunction: A prospective, multi-center study. Int Urol
Nephrol. 45:989–994. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schwinn DA and Roehrborn CG:
Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int
J Urol. 15:193–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Malloy BJ, Price DT, Price RR, Bienstock
AM, Dole MK, Funk BL, Rudner XL, Richardson CD, Donatucci CF and
Schwinn DA: Alpha1-adrenergic receptor subtypes in human detrusor.
J Urol. 160:937–943. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Andersson KE: Mode of action of
alpha1-adrenoreceptor antagonists in the treatment of lower urinary
tract symptoms. BJU Int. 85:(Suppl 2). 12–18. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Michel MC and Vrydag W: Alpha1-, alpha2-
and beta-adrenoceptors in the urinary bladder, urethra and
prostate. Br J Pharmacol. 147:(Suppl 2). S88–S119. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nasu K, Moriyama N, Fukasawa R, Tsujimoto
G, Tanaka T, Yano J and Kawabe K: Quantification and distribution
of α1-adrenoreceptor subtype mRNAs in human proximal urethra. Br J
Pharmacol. 123:1289–1293. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Serels S and Stein M: Prospective study
comparing hyoscyamine, doxazosin, and combination therapy for the
treatment of urgency and frequency in women. Neurourol Urodyn.
17:31–36. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang SJ, Chiang IN and Yu HJ: The
effectiveness of tamsulosin in treating women with voiding
difficulty. Int J Urol. 15:981–985. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Low BY, Liong ML, Yuen KH, Chee C, Leong
WS, Chong WL, Khan NA, Cheah PY and Liong KK: Terazosin therapy for
patients with female lower urinary tract symptoms: a randomized,
double-blind, placebo controlled trial. J Urol. 179:1461–1469.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pummangura N and Kochakarn W: Efficacy of
tamsulosin in the treatment of lower urinary tract symptoms (LUTS)
in women. Asian J Surg. 30:131–137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lepor H and Theune C: Randomized
double-blind study comparing the efficacy of terazosin versus
placebo in women with prostatism-like symptoms. J Urol.
154:116–118. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kakizaki H and Koyanagi T: Current view
and status of the treatment of lower urinary tract symptoms and
neurogenic lower urinary tract dysfunction. BJU Int. 85:(Suppl 2).
25–30. 2000. View Article : Google Scholar : PubMed/NCBI
|
